An official website of the United States government
NIH Guide: Weekly Index for February 9, 2024
Weekly NIH Funding Opportunities and Notices
February 9, 2024
Policy Notices
-
RESCINDED - Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2024
(NOT-HS-24-006)Agency for Healthcare Research and Quality
-
NIH Operates Under a Continuing Resolution
(NOT-OD-24-059)National Institutes of Health
Notice of Changes to Funding Opportunities
-
Notice of NIAMS' Participation in PAR-24-053, "Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)"
(NOT-AR-24-012)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of NCCIH Participation in PAR-23-309 "Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)"
(NOT-AT-24-027)National Center for Complementary and Integrative Health
-
Notice of Change to RFA-DA-23-053, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)"
(NOT-DA-23-054)National Institute on Drug Abuse
-
Notice of Change to section for RFA-DA-25-027: The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
(NOT-DA-23-064)National Institute on Drug Abuse
-
Notice of change of eligibility criteria for RFA-DK-21-033 The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
(NOT-DK-24-012)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
(NOT-FD-24-004)Food and Drug Administration
-
Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
(NOT-FD-24-005)Food and Drug Administration
-
Notice of Change: Extension of PAR-21-153 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)"
(NOT-NS-24-039)National Institute of Neurological Disorders and Stroke
-
Notice of Change: Extension of PAR-21-233 "Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System U44"
(NOT-NS-24-050)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences Research
-
Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
(NOT-NS-24-056)National Institute of Neurological Disorders and Stroke
-
Notice to Rescind NOT-NS-24-038 "Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
(NOT-NS-24-057)National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
-
Notice of Intent to Publish a Notice of Funding Opportunity for Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed)
(NOT-AI-24-015)National Institute of Allergy and Infectious Diseases
Notices of Special Interest
-
Notice of Special Interest (NOSI): National Center for Complementary and Integrative Health (NCCIH) T32 Complementary and Integrative Health Practitioner Supplement Program for Pre- and Postdoctoral Candidates
(NOT-AT-24-033)National Center for Complementary and Integrative Health
-
Notice of Special Interest (NOSI): Administrative Supplements for NCI Division of Cancer Biology Research Programs
(NOT-CA-24-029)National Cancer Institute
-
Notice of Special Interest (NOSI): Administrative Supplements for Contemporary Modifiable Exposures and Cancer Across the Life Course and Cancer Control Continuum
(NOT-CA-24-030)National Cancer Institute
Funding Opportunities
-
AHRQ Health Services Research Projects (R01)
(PA-24-154)Agency for Healthcare Research and QualityApplication Receipt Date(s): July 6, 2029
-
AHRQ Small Health Services Research Grant Program (R03)
(PA-24-155)Agency for Healthcare Research and QualityApplication Receipt Date(s): July 17, 2029
-
AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
(PA-24-156)Agency for Healthcare Research and QualityApplication Receipt Date(s): May 26, 2029
-
The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
(PAR-24-117)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
(PAR-24-118)National Institute of Mental HealthNational Institute on Drug AbuseApplication Receipt Date(s): January 7, 2025
-
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
(PAR-24-125)National Center for Complementary and Integrative HealthApplication Receipt Date(s): July 18, 2024
-
NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
(PAR-24-127)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Multiple dates, see announcement.
-
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required)
(PAR-24-140)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): May 7, 2027
-
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required)
(PAR-24-142)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): May 7, 2027
-
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Not Allowed)
(PAR-24-143)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): May 7, 2027
-
Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed)
(PAR-24-147)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): October 4, 2024
-
Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed)
(PAR-24-148)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): October 4, 2024
-
Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)
(RFA-AG-25-016)National Institute on AgingApplication Receipt Date(s): June 13, 2024
-
Drug Development Tools Research Grants (U01) Clinical Trials Optional
(RFA-FD-24-030)Food and Drug AdministrationApplication Receipt Date(s): May 13, 2025
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster